Shree Ganesh Bio-Tech (India) informs about quarterly statement of investor complaints

06 Jul 2017 Evaluate

In compliance with Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Bio-Tech (India) has informed about quarterly statement of Investor Complaints as per Regulation 13 (3) Of SEBI (LODR) Regulation, 2015.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh BioTech Share Price

0.57 -0.01 (-1.72%)
13-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1213.65
Mangalam Global Ent 10.21
Kaveri Seed 810.40
Regaal Resources 90.61
Simran Farms 148.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×